04:34 PM EDT, 08/07/2025 (MT Newswires) -- Gilead Sciences ( GILD ) reported fiscal Q2 adjusted earnings late Thursday of $2.01 per diluted share, unchanged from a year earlier. Analysts polled by FactSet expected $1.96. Revenue for the quarter ended June 30 was $7.08 billion, up from $6.95 billion a year earlier. Analysts surveyed by FactSet expected $6.98 billion. The...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Overview * Grove Q2 revenue falls 15.5% yr/yr to $44.0 mln, sequentially up 1.1% * Net loss improves to $3.6 mln from $10.1 mln last year * Adjusted EBITDA negative $0.9 mln, down from $1.1 mln last year Outlook * Grove expects Q3 revenue to improve, Q4 revenue to grow year-over-year * Full-year 2025 revenue expected to decline mid-single to...

Overview * OptimizeRx ( OPRX ) Q2 revenue grows 55% yr/yr, beating analyst expectations, per LSEG data * Adjusted EBITDA for Q2 beats consensus, reflecting strong operational performance * Co raises full-year 2025 guidance for revenue and adjusted EBITDA Outlook * Company raises 2025 revenue guidance to $104 mln-$108 mln * OptimizeRx ( OPRX ) expects 2025 adjusted EBITDA of...